Statins provide no beneficial effect on coronary heart disease in trials since 2004-2005

Posted by .(JavaScript must be enabled to view this email address)
Tuesday, July 19, 2016 11:13 am Email this article

“After 2004–2005 [when new penalties were put in place regarding clinical trials in the EU], all clinical trials, performed by scientists relatively free of conflict of interest with pharmaceutical industries, reported… no significant beneficial effects were observed [with the use of statins] for the prevention of CHD [coronary heart disease],” according to a 2015 review paper by Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, Peter H. Langsjoen MD, a cardiologist from Texas, and others who reviewed more than 20 statin drug studies done after 2004.

“Currently, the majority of scientists continue to claim that statins are effective in preventing CHD [coronary heart disease], but these claims are based on meta-analyses of reports, including those published before the EU regulation (mostly in 1990s) [which are unreliable].”

Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’

    “We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
    “I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.

Peter Langsjoen, MD: ‘These drugs [statins] should never have been approved for use.’

    “These drugs [statins] should never have been approved for use.
    “The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of this 2015 review paper, was quoted as saying in the UK newspaper The Daily Express.

Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’

    “This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.

This article was originally posted on Jan 11, 2016.

 

 

Reference

Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.

Author’s Contact Info

Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
.(JavaScript must be enabled to view this email address)

Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
.(JavaScript must be enabled to view this email address)

Articles on the same subject can be found here:

• Statins